Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
|Articles|November 6, 1996
Digirad applies for FDA clearance
Digital gamma camera developer Digirad of San Diego hasfiled forregulatory clearance with the Food and Drug Administration forits lead product, Notebook Imager. If and when the applicationis cleared, Notebook Imager will become the first solid-stategamma
Advertisement
Digital gamma camera developer Digirad of San Diego hasfiled forregulatory clearance with the Food and Drug Administration forits lead product, Notebook Imager. If and when the applicationis cleared, Notebook Imager will become the first solid-stategamma camera to be marketed commercially.
Notebook Imager is a portable gamma camera that uses a cadmiumzinc telluride detector array rather than scintillation crystalsand photomultiplier tubes, as conventional Anger-style camerasdo (SCAN 6/5/96). Digirad hopes to receive FDA clearance and beginmarketing the system next year.
To help ramp up its manufacturing and product-testing effort,Digirad completed a $6 million financing issued to a group ofventure-capital firms. Proceeds from the funding will be usedto finish beta-site testing and develop a manufacturing capacityfor Notebook Imager. The funding was led by Sorrento Ventures,and included Kingsbury Capital Partners and several individualinvestors.
Advertisement
Related to this article
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
2
Radiology and Building the Alzheimer’s Care Pathway of the Future
3
Current Perspectives on Integrating AI into Radiology
4
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
5